AIMS: The aim of this study was to determine whether intermittent ambulatory treatment with levosimendan would improve functional capacity, quality of life, and event-free survival in patients with advanced heart failure. METHODS AND RESULTS: This was a prospective, randomized, double-blind, placebo...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!